In Vienna, Valneva is focused on vaccines and pre-clinical and clinical development activities. The site is located at the Vienna Biocenter campus, a melting pot of biotechnology and life sciences in Vienna. The facilities accommodate departments for vaccine research, (technical/clinical) product development, quality, regulatory affairs, as well as general and administrative functions.
In addition to using its latest-stage laboratory facilities for R&D activities, the site holds a certificate of Good Manufacturing Practice (GMP) from the Austrian Agency for Health and Food Safety (AGES) for its Quality Control laboratories and was successfully licensed by the US Food and Drug Administration (FDA).
Around 150 employees are based in Vienna, focusing on R&D, as well as supporting the company's first commercial product on the market, a vaccine against Japanese encephalitis.
Valneva Austria GmbH
Campus Vienna Biocenter 3
1030 Vienna, Austria
+43 1 20620F
+43 1 20620 email@example.com